JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, A. W.
Right arrow Articles by Garland, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, A. W.
Right arrow Articles by Garland, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 33, 17322-17332, 11, 1988

Mechanism of androstenedione formation from testosterone and epitestosterone catalyzed by purified cytochrome P-450b

AW Wood, DC Swinney, PE Thomas, DE Ryan, PF Hall, W Levin and WA Garland
Department of Oncology, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.

A purified rat hepatic monooxygenase system containing cytochrome P- 450b oxidizes testosterone to androstenedione and 16 alpha- and 16 beta- hydroxytestosterone at approximately equal rates. The metabolism of epitestosterone by the same system is characterized by a marked stereoselectivity in favor of 16 beta-hydroxylation (4- to 5-fold relative to 16 alpha-hydroxylation), formation of 15 alpha- hydroxyepitestosterone, and a rate of androstenedione formation which is three to five times higher than that observed with testosterone. Apparent Km values for 16 alpha- and 16 beta-hydroxylation and androstenedione formation are 20-30 microM with either substrate. Mass spectral analysis of the androstenedione formed from [16,16- 2H2]testosterone and [16,16-2H2] epitestosterone indicates essentially complete retention of deuterium, thereby ruling out a mechanism of androstenedione formation via C-16 hydroxylation followed by loss of water and rearrangement. Mass spectral analysis of the C-16 hydroxylation products from incubations of testosterone or epitestosterone in 18O2 shows essentially complete incorporation of 18O (greater than 95%). Androstenedione formed from testosterone is enriched in 18O only 2-fold (5-8%) over background, while the androstenedione formed from epitestosterone shows 84% enrichment. Kinetic experiments utilizing [17-2H]testosterone and [17- 2H]epitestosterone as substrates indicate that cleavage of the C-17 carbon-hydrogen bond is involved in a rate-limiting step in the formation of androstenedione from both substrates. Taken together, our results indicate that androstenedione formation from epitestosterone proceeds exclusively through the gem-diol pathway, while androstenedione formation from testosterone may proceed through a combination of gem-diol and dual hydrogen abstraction pathways.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Zhao, X. Lin, L. Lei, D. C. Lamb, S. L. Kelly, M. R. Waterman, and D. E. Cane
Biosynthesis of the Sesquiterpene Antibiotic Albaflavenone in Streptomyces coelicolor A3(2)
J. Biol. Chem., March 28, 2008; 283(13): 8183 - 8189.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. H. Choi, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum
CHARACTERIZATION OF TESTOSTERONE 11{beta}-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450
Drug Metab. Dispos., June 1, 2005; 33(6): 714 - 718.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Matsunaga, H. Tanaka, S. Higuchi, K. Shibayama, N. Kishi, K. Watanabe, and I. Yamamoto
Oxidation Mechanism of 7-Hydroxy-Delta 8-tetrahydrocannabinol and 8-Hydroxy-Delta 9-tetrahydrocannabinol to the Corresponding Ketones by CYP3A11
Drug Metab. Dispos., November 1, 2001; 29(11): 1485 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. Matsunaga, N. Kishi, S. Higuchi, K. Watanabe, T. Ohshima, and I. Yamamoto
CYP3A4 Is a Major Isoform Responsible for Oxidation of 7-Hydroxy-Delta 8-tetrahydrocannabinol to 7-Oxo-Delta 8-tetrahydrocannabinol in Human Liver Microsomes
Drug Metab. Dispos., November 1, 2000; 28(11): 1291 - 1296.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.